RECENT NEWS

Thermo Fisher Scientific and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.

The government has published a new plan to promote cyber resilience across the health and care sectors by 2030, protecting both services and patients.

National pharmacy retail chain Boots has announced a UK-wide diabetes screening pilot which will offer a private screening service to customers using the LumiraDx platform and HbA1c test.

Bio-Rad Laboratories has launched the new PTC Tempo 96 and PTC Tempo Deepwell thermal cyclers, designed to optimise PCR applications such as sequencing, cloning, and genotyping.

Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, announced it has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.

A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners to make it faster and easier to gain approval and to run clinical trials in the UK.

PerkinElmer has successfully completed the previously announced divestiture of its applied, food and enterprise services businesses to New Mountain Capital, a growth-oriented investment firm.

Proscia, a leading provider of digital and computational pathology solutions, has strengthened its position in the $12 billion preclinical research and development (R&D) market with enhancements to its flagship Concentriq for Research platform.

NADMED, a start-up that offers kits and laboratory services for the measurement of NADs from any biological sample, has announced a partnership with health data company and CLIA-certified laboratory TruDiagnostic to launch a novel NAD blood test in the United States.

Dr Nicole Robb, Assistant Professor at Warwick University, Oxford University lecturer, and co-founder of healthtech company Pictura Bio, has today warned that the UK’s diagnostic testing capabilities are not advanced enough to deal with an influenza spill-over event from birds to humans quickly and efficiently. Dr Robb believes that new diagnostic technologies are needed as a priority.

INTEGRA Biosciences has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols.

Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) has launched a £3 million Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF.

London Medical Laboratory (LML) has improved its efficiency and enhanced annual revenue growth by deploying Cirdan’s next-generation laboratory information system, ULTRA. ULTRA improves the quality of patient care by delivering more timely and accurate results to both clinicians and patients.

HM Treasury has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million to help bring innovative new medicines and medical technologies to UK patients more quickly.

In his Spring Budget today, 15 March, the Chancellor of the Exchequer, Jeremy Hunt has announced future changes for the Medicines and Healthcare products Regulatory Agency (MHRA).

Owlstone Medical the developer of Breath Biopsy for applications in early disease detection and precision medicine, has entered into a research agreement with Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology.

Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, diagnostics and pharma to improve their quality control (QC) process.

The UK Transfusion Laboratory Collaborative (UKTLC) has revised its minimum standards for 2023, with an abridged version now available on the Serious Hazards Of Transfusion (SHOT) website.

The 2023 Advancing Healthcare Awards has unveiled its shortlist ahead of the awards lunch and presentation ceremony taking pace on 21 April. The awards recognise and celebrate the work of allied health professionals, healthcare scientists and those who work alongside them in support roles, leading innovative healthcare practice across the UK.

Thermo Fisher Scientific Microbiology has achieved International Organization for Standardization (ISO) 17034 certification, making it an accredited reference material (RM) manufacturer of certified reference material (CRM) quality control products.